Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy.


Journal

European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263

Informations de publication

Date de publication:
14 05 2020
Historique:
received: 01 04 2020
revised: 17 04 2020
accepted: 06 05 2020
pubmed: 10 5 2020
medline: 20 5 2020
entrez: 9 5 2020
Statut: ppublish

Résumé

To compare demographic characteristics, clinical presentation, and outcomes of patients with and without concomitant cardiac disease, hospitalized for COVID-19 in Brescia, Lombardy, Italy. The study population includes 99 consecutive patients with COVID-19 pneumonia admitted to our hospital between 4 March and 25 March 2020. Fifty-three patients with a history of cardiac disease were compared with 46 without cardiac disease. Among cardiac patients, 40% had a history of heart failure, 36% had atrial fibrillation, and 30% had coronary artery disease. Mean age was 67 ± 12 years, and 80 (81%) patients were males. No differences were found between cardiac and non-cardiac patients except for higher values of serum creatinine, N-terminal probrain natriuretic peptide, and high sensitivity troponin T in cardiac patients. During hospitalization, 26% patients died, 15% developed thrombo-embolic events, 19% had acute respiratory distress syndrome, and 6% had septic shock. Mortality was higher in patients with cardiac disease compared with the others (36% vs. 15%, log-rank P = 0.019; relative risk 2.35; 95% confidence interval 1.08-5.09). The rate of thrombo-embolic events and septic shock during the hospitalization was also higher in cardiac patients (23% vs. 6% and 11% vs. 0%, respectively). Hospitalized patients with concomitant cardiac disease and COVID-19 have an extremely poor prognosis compared with subjects without a history of cardiac disease, with higher mortality, thrombo-embolic events, and septic shock rates.

Identifiants

pubmed: 32383763
pii: 5834516
doi: 10.1093/eurheartj/ehaa388
pmc: PMC7239204
doi:

Substances chimiques

Peptide Fragments 0
Troponin T 0
pro-brain natriuretic peptide (1-76) 0
Natriuretic Peptide, Brain 114471-18-0
Creatinine AYI8EX34EU

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1821-1829

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : ErratumIn
Type : CommentIn

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Références

JACC Heart Fail. 2016 Jul;4(7):591-599
pubmed: 27039129
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
JAMA Intern Med. 2020 Mar 13;:
pubmed: 32167524
Eur Heart J. 2020 Mar 16;:
pubmed: 32176778
Hypertension. 2020 Jun;75(6):1382-1385
pubmed: 32208987
JAMA Cardiol. 2020 Mar 27;:
pubmed: 32219363
Eur J Heart Fail. 2019 Jun;21(6):715-731
pubmed: 31222929
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556
JAMA Cardiol. 2020 Mar 25;:
pubmed: 32211816
N Engl J Med. 2020 May 21;382(21):2012-2022
pubmed: 32227758
Nat Rev Cardiol. 2020 May;17(5):259-260
pubmed: 32139904
N Engl J Med. 2020 Apr 23;382(17):1653-1659
pubmed: 32227760
JAMA. 2020 Mar 13;:
pubmed: 32167538
JAMA Cardiol. 2020 Mar 27;:
pubmed: 32219356
Eur Heart J. 2018 Oct 14;39(39):3615-3617
pubmed: 28525640
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Crit Care. 2019 Nov 27;23(1):374
pubmed: 31775846
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
Eur J Heart Fail. 2019 Aug;21(8):965-973
pubmed: 31087601
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
JAMA. 2020 Mar 19;:
pubmed: 32191259
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
Eur Heart J. 2020 Feb 01;:
pubmed: 32006431
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
JAMA. 2016 Feb 23;315(8):762-74
pubmed: 26903335
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632

Auteurs

Riccardo M Inciardi (RM)

Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Marianna Adamo (M)

Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Laura Lupi (L)

Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Dario S Cani (DS)

Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Mattia Di Pasquale (M)

Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Daniela Tomasoni (D)

Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Leonardo Italia (L)

Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Gregorio Zaccone (G)

Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Chiara Tedino (C)

Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Davide Fabbricatore (D)

Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Antonio Curnis (A)

Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Pompilio Faggiano (P)

Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Elio Gorga (E)

Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Carlo M Lombardi (CM)

Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Giuseppe Milesi (G)

Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Enrico Vizzardi (E)

Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Marco Volpini (M)

Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Savina Nodari (S)

Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Claudia Specchia (C)

Department of Molecular and Translational Medicine, University of Brescia, Brescia Italy.

Roberto Maroldi (R)

Institute of Radiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Michela Bezzi (M)

Respiratory Unit, ASST Spedali Civili di Brescia, Brescia, Italy.

Marco Metra (M)

Institute of Cardiology, ASST Spedali Civili di Brescia and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH